CONCENTRIX CORPORATION
CONCENTRIX CORPORATION (CNXC) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.
The headline says Concentrix lost nearly a billion dollars at the operating line last year, but almost all of it is a non-cash item: a $1,523.3 million goodwill impairment tied to the depressed stock price and the Webhelp acquisition. Underneath it, fiscal 2025 cash from operations was a record $807 million and adjusted free cash flow was $626 million. That gap is why the stock is cheap. At $25.08 it trades around half of book value of about $45 per share, and the cash-flow methods land far abo
Is CNXC overvalued? See what's priced in →
283 institutional managers reported holding CNXC in 13F filings for the quarter ended 2026-03-31. 44 opened new positions that quarter. Held by Vanguard Group, AQR Capital, FMR (Fidelity), among others. On the short side, 10.1M shares were sold short as of the 2026-06-15 count, about 16% of shares outstanding (9.3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CNXC's share count grew 19.5% over the past five years even with $557.87M spent on repurchases. It pays a dividend, and has paid one every year in our records (5 and counting), raised 4 years straight. Cash returned over the past three years: $231.44M in dividends and $397.01M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at CNXC over the trailing three years: 2023: 3 buys totaling $64k; 2024: 4 buys totaling $116k; 2025: 6 buys totaling $288k; 2026: 2 buys totaling $64k. 16 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CNXC's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-08 | -3.5% | -13.1% |
| 2023-10-07 | +10.9% | +17.5% |
| 2024-01-30 | -16.4% | -31.6% |
| 2024-04-06 | +4.1% | +4.0% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CNXC's latest 8-K filings: 2026-06-29 (items 2.02, 9.01); 2026-05-01 (items 5.02); 2026-03-27 (items 5.02, 5.07, 9.01); 2026-03-24 (items 2.02, 9.01); 2026-03-23 (items 1.01, 2.03, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.